Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Urology|March 19, 2004
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinomaAlessandro Sciarra, Franco Di Silverio
The Journal of Urology|October 9, 2003
Combination therapy of ethinylestradiol and somatostatin analogue reintroduces objective clinical responses and decreases chromogranin a in patients with androgen ablation refractory prostate cancerFranco Di Silverio, Alessandro Sciarra
Urologia Internationalis|February 14, 2004
Antiandrogen monotherapy: recommendations for the treatment of prostate cancerAlessandro Sciarra, Antonio Cardi, Franco Di Silverio
Urology|February 19, 2008
Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomyFranco Di Silverio, Alessandro Sciarra, Vincenzo Gentile
Anticancer Research|April 20, 2006
Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancerMaria Rosaria Cardillo, Franco Di Silverio, Vincenzo Gentile
Urology|December 15, 2004
Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancerCostantino Cerulli, Alessandro Sciarra, Gianfilippo Salvatori, et al.
Reviews on Recent Clinical Trials|May 14, 2008
New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): current status and future prospectsAlessandro Sciarra, Vincenzo Gentile, Stefano Salciccia, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 25, 2005
Which patients with prostate cancer are actually candidates for hormone therapy?Alessandro Sciarra, Antonio Cardi, Gianfilippo Salvatori, et al.
Urology|December 20, 2005
Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostateAlessandro Sciarra, Stefano Salciccia, Luca Albanesi, et al.
Anticancer Research|December 12, 2003
Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancerMaria Rosaria Cardillo, Salvatore Monti, Franco Di Silverio, et al.
Pageof 5